These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 19594841

  • 1. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D, Richardson D, Eisa M, Bajwa RJ, Jabbari B.
    Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 3. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
    Singh JA, Mahowald ML, Noorbaloochi S.
    Transl Res; 2009 May; 153(5):205-16. PubMed ID: 19375681
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 6. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C, Yariv S, Adler R, Badarny S, Eisenberg E.
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A, Barnes M, Comiskey C.
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.
    Boon AJ, Smith J, Dahm DL, Sorenson EJ, Larson DR, Fitz-Gibbon PD, Dykstra DD, Singh JA.
    PM R; 2010 Apr; 2(4):268-76. PubMed ID: 20430328
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL, Lee EH, Castaneda A, Klima R, Date E.
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [Abstract] [Full Text] [Related]

  • 10. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
    Freund BJ, Schwartz M.
    J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group.
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [Abstract] [Full Text] [Related]

  • 12. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC, Chancellor MB.
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [Abstract] [Full Text] [Related]

  • 13. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
    Nagarajan V, Al-Shubaili A, Ayad YM, Alexander J, Al-Ramezi K.
    Med Princ Pract; 2007 Sep; 16(3):181-6. PubMed ID: 17409751
    [Abstract] [Full Text] [Related]

  • 14. Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study.
    Jabbari B, Ney J, Sichani A, Monacci W, Foster L, Difazio M.
    Pain Med; 2006 Sep; 7(3):260-4. PubMed ID: 16712627
    [Abstract] [Full Text] [Related]

  • 15. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW.
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [Abstract] [Full Text] [Related]

  • 16. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG, Bang MS, Chung SG, Jung SH, Lee SU.
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
    Tobinick E, Davoodifar S.
    Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ, Krack P, BoNTTH Study Group.
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
    Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM.
    Headache; 2004 Sep; 44(8):794-800. PubMed ID: 15330826
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH, Neo JJ, Chua KS.
    Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.